how to know if semaglutide is right for me You? How Do You Know When

Many patients notice significant improvements in their body composition within just 3 to 6 months

On the back of phase II trials, its already being hailed as a game-changer

As a result, patients with largely postprandial hyperglycaemia are more likely to benefit from treatment with short-acting GLP1-RAs as opposed to individuals with predominantly fasting hyperglycaemia, who would derive greater benefit from long-acting agents [52]

Aronne L, Fujioka K, Aroda V, et al

In contrast, when discussing tirzepatide vs retatrutide, it is notable that retatrutide is a novel triple agonist that activates GLP-1, GIP, and glucagon receptors